The Dual Transporter Inhibitor Duloxetine: A Review of its Preclinical Pharmacology, Pharmacokinetic Profile, and Clinical Results in Depression

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|12|1475-1493

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.12, 2005-05, pp. : 1475-1493

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preclinical discovery of duloxetine for the treatment of depression

By Torres-Sanchez Sonia   Perez-Caballero Laura   Mico Juan Antonio   Elorza Julian   Berrocoso Esther  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 8, 2012-08 ,pp. : 745-755

Informa Healthcare

Access to resources Recommend Favorite

Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials

By  

Current Cancer Drug Targets, Vol. 11, Iss. 3, 2011-03 ,pp. : 254-284

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical pharmacology review of escitalopram for the treatment of depression

By Pastoor Devin   Gobburu Joga  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 1, 2014-01 ,pp. : 121-128

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacokinetic and Pharmacodynamic Profile of the HIV Integrase Inhibitor Elvitegravir

By Ramanathan Srinivasan   Mathias Anita A.   German Polina   Kearney Brian P.  

Clinical Pharmacokinetics, Vol. 50, Iss. 4, 2011-04 ,pp. : 229-244

Adis International

Access to resources Recommend Favorite

The hepatic safety profile of duloxetine: a review

By McIntyre Roger S   Panjwani Zilomi D   Nguyen Ha T   Woldeyohannes Hanna O   Alsuwaidan Mohammad   Soczynska Joanna K   Lourenco Maria T   Konarski Jakub Z   Kennedy Sidney H  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 3, 2008-03 ,pp. : 281-285

Informa Healthcare

Access to resources Recommend Favorite